Quarterly report pursuant to Section 13 or 15(d)

Earnings (Loss) Per Common Share (EPS) - Antidilutive Securities (Details)

v3.19.3
Earnings (Loss) Per Common Share (EPS) - Antidilutive Securities (Details)
 3 Months Ended 6 Months Ended 9 Months Ended
Sep. 30, 2019
$ / shares
shares
Mar. 31, 2019
shares
Sep. 30, 2018
shares
Sep. 30, 2019
$ / shares
shares
Sep. 30, 2018
shares
Jun. 30, 2019
shares
Dec. 31, 2018
shares
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]              
Incentive program, exercise price (in dollars per share) | $ / shares $ 23            
Exercise price (in dollars per share) | $ / shares $ 48.85     $ 48.85      
Preferred stock, shares outstanding (in shares)           500,000 500,000
Preferred stock, conversion ratio           47.6190  
Successor unvested restricted stock units              
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]              
Shares excluded from diluted EPS (in shares) 198,765 0 0 198,765 0    
Successor stock options              
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]              
Shares excluded from diluted EPS (in shares) 298,150 0 0 298,150 0    
Successor warrants              
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]              
Shares excluded from diluted EPS (in shares) 2,580,182 0 0 2,580,182 0    
Preferred Stock              
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]              
Shares excluded from diluted EPS (in shares) 0 1,587,300 1,587,300 0 1,587,300